Wipfli Financial Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Wipfli Financial Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$9K	Buy	+331	New	+$10.8K	﹤0.01%	1866

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wipfli Financial Advisors's AMPH Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Amphastar Pharmaceuticals (AMPH) in Q3 2022: 331 shares worth $9K. The stake represents ﹤0.01% of the portfolio and ranks #1866 among its holdings.

205 funds tracked by Wall St. Rank hold AMPH as of Q3 2022.

Wipfli Financial Advisors held 331 shares of Amphastar Pharmaceuticals worth $9K as of Q3 2022.
Amphastar Pharmaceuticals was a new Wipfli Financial Advisors position in Q3 2022.
Amphastar Pharmaceuticals made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #1866 holding.
205 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.